🔤 ABCs of #ONCOSCREEN
G = Gastroenterology
Gastroenterologists are at the heart of CRC prevention, combining clinical expertise, innovation & patient care to improve screening and outcomes across Europe. 💙
@oncoscreen-project.bsky.social
A European “shield” against colorectal cancer based on novel, more precise and affordable risk-based screening methods and viable policy pathways
🔤 ABCs of #ONCOSCREEN
G = Gastroenterology
Gastroenterologists are at the heart of CRC prevention, combining clinical expertise, innovation & patient care to improve screening and outcomes across Europe. 💙
📢 New Publication: A Decision Support Model for Colorectal Cancer Screening
Our latest research introduces a personalised model that tailors CRC screening based on individual risk factors.
Read more here 👉 oncoscreen.health/2025/09/23/p...
🔍 Partner Insights Series: Catalink Spotlight
We’re excited to share our latest video in the ONCOSCREEN Partner Insights series, this time featuring Catalink Ltd!
Watch the full video here:
👉 youtu.be/7w-n_hGOJeM
🔤 ABCs of #ONCOSCREEN
F = Fundamental Rights in Healthcare
Everyone deserves equal, timely & effective access to care. Our approach to CRC screening puts fairness, accessibility & patient rights at the core.
#CancerPrevention #HealthcareForAll #MissionCancerEU
🚀 NEW: #ONCOSCREEN Partner Spotlight!
Meet Rosenbaum Group—clinical research experts in the CEE region, supporting trials for over 1,100 patients across 🇬🇷🇭🇺🇸🇰🇨🇿🇧🇬.
Fast, high-quality, and patient-focused.
🎥 Watch Ep.1 👉 youtu.be/6ljfhQiMHxI
🏛️ How does #ONCOSCREEN work with governments to improve colorectal cancer screening?
By embedding innovation directly into public systems, the project is aligning tech, policy & practice across Europe.
Read the blog 👉 oncoscreen.health/2025/08/01/h...
🗣️ From co-creation workshops to national dialogues, discover how patients are helping shape a more inclusive, effective, and human-centered approach to CRC prevention.
📖 Full Blog here:https://oncoscreen.health/2025/07/10/patient-engagement-within-oncoscreen/
🚨 Big ideas for the future of colorectal cancer screening!
The #ONCOSCREEN Plenary & Living Labs Day sparked key discussions on tech, policy & patient-centered innovation in CRC screening.
Catch the highlights 👉 oncoscreen.health/2025/06/17/o...
📊 How can policymakers make smarter, data-driven decisions about colorectal cancer (CRC) screening?
This Blog explores how Onco-Evida, was designed with input from public health experts, and built to turn complex data into actionable knowledge.
More: oncoscreen.health/2025/06/17/o...
✨ NEW BLOG ✨
How can we make colorectal cancer screening smarter, safer & more accessible?
#ONCOSCREEN is building a next-gen system with AI, co-design & privacy-first architecture—shaped by clinicians, patients & policymakers.
👉 oncoscreen.health/2025/05/28/i...
#DigitalHealth #MissionCancerEU
Day 4 of the #ONCOSCREEN Plenary is all about the ONCOLOGICAL Living Labs! 🤝 Our partners have gathered for an interactive session led by industry experts
🔹 Focus on CRC policy, financing & citizen engagement
🔹 Next steps: ONCOTHON & future Living Labs planning!
🔬 Wrapping up Day 3 of the #ONCOSCREEN Plenary with tool demos & real-world testing!
🛠️ From ONCOCRISPR to ONCOVOC, partners showcased diagnostic tools & AI platforms
✅ Evaluation led by ICCS & POLA ensured tools meet user needs
Collaboration in action! 🚀
🎯 Day 3 of the #ONCOSCREEN Plenary kicks off with our Oncological Living Lab on CRC Tools!
Patients, clinicians & policymakers are testing ONCOSCREEN innovations hands-on—from #AI-powered diagnostics to privacy-preserving platforms.
Real users. Real feedback. Real impact. 🔍💬
This afternoon at the #ONCOSCREEN Plenary
🛡️ Risk mitigation strategies for clinical trials with UMC Mainz & @FiralisGroup
🔧 System architecture finalisation with ICCS
💼 IPR & exploitation planning with @exus_AILabs
🗣️ Citizen awareness workshop led by Europacolon
Day 2 of the #ONCOSCREEN Plenary is off to a strong start in Kaunas! 🌤️
This morning, we’re diving into:
🔹 Dissemination, communication & impact strategies with @CarrCommsLtd
🔹 Clinical trial design & validation insights lead by @FiralisGroup
Stay tuned for more!
Our morning will now continue with opening remarks and updates from our project co-ordinator Exus AI Solutions and Project Partner UMC - Mainz
19.05.2025 09:41 — 👍 0 🔁 0 💬 0 📌 0🎓 The 2nd ONCOSCREEN Plenary Meeting kicks off in Kaunas with a deep dive into cutting-edge research at LSMU! From nuclear medicine to regenerative therapies, today’s site visit showcases how Lithuanian science is shaping the future of cancer screening.
19.05.2025 09:41 — 👍 1 🔁 1 💬 1 📌 0#ONCOSCREEN's next Plenary Meeting is coming up!
Our partners are preparing to travel to Kaunas, Lithuania on May19-22 for the second Plenary of the project.
This will be a great opportunity to share progress updates and lay the groundwork for the next phase.
Some of our project partners who proudly represented the Oncoscreen Project at the 1st Styrian Run Against Cancer on April 26th, 2025! Organised by the Comprehensive Cancer Center (CCC) Graz at Universitätsklinikum Landeskrankenhaus.
Learn more 👉 run-against-cancer.at
✳️ #ONCOSCREEN Introduction series ✳️
Our next partner is the Hellenic Society of Gastrointestinal Oncology
➡️ Learn more about HSGO: digestiveoncology.org.gr/en/
2️⃣ Special Session on Disruptive Technologies for Smart Verticals at IEEE BlackSeaCom 2025. 🗓 Submission Deadline: April 30, 2025 🔗 ow.ly/eqIa50Vxs1q
Let’s drive the future of innovation in healthcare and security—together.
Upcoming Conferences:
1️⃣ IWAPS 2025 – 5th International Workshop on Advances on Privacy Preserving Technologies and Solutions, part of ARES 2025 in Ghent, Belgium. 🗓 Submission Deadline: May 12, 2025 🔗 ow.ly/bnE150Vxs1t
Why Participate?
✔️ Contribute to cutting-edge discussions on privacy-preserving AI and disruptive technologies.
✔️ Engage with experts shaping the future of secure and personalized healthcare solutions.
🔬 INNOVATE TO TRANSFORM HEALTHCARE!
#ONCOSCREEN is excited to support two leading conferences at the intersection of AI, cybersecurity, and digital transformation.
Fear of a cancer diagnosis is a significant barrier to CRC screening uptake, with only 41% participation last year. Early detection is crucial, as bowel cancer is one of the most treatable forms when caught early. Learn more: ow.ly/6PjA50Vt0Mx
02.04.2025 11:15 — 👍 1 🔁 0 💬 0 📌 0🔤 The A-Z of #ONCOSCREEN 🔤
D is for Data Anonymisation
Data anonymisation is a critical process we employ to protect individuals' identities by removing personally identifiable information from datasets.
Find out more:https://oncoscreen.health/
🚀 Strategies to Mitigate Financial Barriers in Colorectal Cancer Screening
In our latest blog, we explore innovative approaches to reduce financial obstacles and ensure equitable access to early detection and care.
Read the full article: ow.ly/eeIR50VpV3V
🚀 Addressing Social Challenges in Colorectal Cancer Screening
In our latest blog, we explore the key social challenges in screening implementation and the strategies to overcome them for a healthier future.
🔍 Read the full article: ow.ly/wH5J50Vkyr7
📣Incase you missed it📣
The full-length recording of the webinar, which featured experts from EXUS AI LABS, @Konnektable Technologies Ltd., National Kapodistrian University of Athens and is now available on Youtube!
Watch the webinar here: lnkd.in/egTT-CSU
🚀 Navigating Ethical Barriers in CRC Screening
In our latest blog, we dive into the ethical considerations surrounding financial schemes and how we can overcome these barriers to improve access to life-saving screening.
🔍 Read the full article: ow.ly/jmjP50Vi2lT